
- AbbVie Inc. (ABBV) Stock Price, News, Quote & History - Yahoo …- Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. 
- AbbVie Inc. (ABBV) Valuation Measures & Financial Statistics- Find out all the key statistics for AbbVie Inc. (ABBV), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. 
- AbbVie Inc. (ABBV)- See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 
- AbbVie Inc. (ABBV) Latest Stock News & Headlines - Yahoo Finance- Get the latest AbbVie Inc. (ABBV) stock news and headlines to help you in your trading and investing decisions. 
- ABBV Interactive Stock Chart | AbbVie Inc. Stock - Yahoo Finance- At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your … 
- AbbVie Inc. (ABBV) Stock Historical Prices & Data - Yahoo Finance- Discover historical prices for ABBV stock on Yahoo Finance. View daily, weekly or monthly format back to when AbbVie Inc. stock was issued. 
- AbbVie Inc. (ABBV) Stock Forum & Discussion - Yahoo Finance- Find the latest AbbVie Inc. (ABBV) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 
- AbbVie Inc. (ABBV) Company Profile & Facts - Yahoo Finance- See the company profile for AbbVie Inc. (ABBV) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives … 
- AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why- Mar 24, 2025 · AbbVie (ABBV) closed the most recent trading day at $209.17, moving -0.4% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of … 
- AbbVie Inc. (ABBV) Stock Major Holders - Yahoo Finance- AbbVie Inc. insiders reported 3 award transactions totaling $56,727.30 on September 30, 2025. All transactions involved stock equivalent units granted to directors and an officer.